Bacteriostatic water and peptide stability

What bacteriostatic water is

Bacteriostatic water is sterile water for injection that has had a small quantity of a preservative, most commonly benzyl alcohol at around 0.9%, added to it. The preservative does not sterilise the solution outright, but it inhibits the growth of most common bacteria across multiple accesses of the same container, which is why it is the standard diluent used when a lyophilised peptide vial needs to be reconstituted more than once before it is used up.

Plain sterile water without a preservative is generally intended for single, immediate use once opened, since it offers no protection against microbial growth if the container is accessed again later.

Why lyophilised peptides need reconstitution

As covered in our storage guide, lyophilised (freeze-dried) peptide powder is stable specifically because it lacks the water needed for most degradation reactions. To use it, the powder has to be reconstituted, meaning a diluent such as bacteriostatic water is added back to dissolve it into solution. From that point, the clock on in-solution stability starts, and standard refrigerated storage and light protection become important, as covered in our storage guide.

Buffers and pH

Beyond the diluent itself, many peptide formulations include a buffering agent, such as Tris (tris(hydroxymethyl)aminomethane), to hold the solution's pH within a narrow, stable range. pH matters because many peptides are more prone to hydrolysis or aggregation outside their optimal pH window, so a well-buffered formulation can meaningfully improve how much intact peptide remains over the useful life of the product.

Why Celyfe pens need none of this

Because every Celyfe pen ships with a cartridge that is already pre-filled and pre-mixed, there is no reconstitution step for the end user to perform, and therefore no need to source or add bacteriostatic water at all. The formulation and any buffering needed to support in-solution stability are handled during manufacture, before the cartridge is sealed and shipped cold-chain. Celyfe's published certificates are HPLC purity and content reports; they do not cover buffer composition, sterility or endotoxin.

Where reconstitution risk comes from

When reconstitution is required, most of the practical risk in a research setting comes from the handling itself: incorrect diluent volume changing the intended concentration, non-aseptic technique introducing contamination, or repeated access degrading the septum and increasing contamination risk over time. A pre-mixed, single pen-and-cartridge system removes this step from the workflow entirely, which is one of the main practical advantages of that format over a vial requiring reconstitution.

Research use only

This guide describes formulation chemistry relevant to laboratory handling of research peptides. It does not describe or imply reconstitution, preparation or administration for use in or on a human or animal body.